Status:
UNKNOWN
Community-based Helicobacter Pylori Eradication
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Helicobacter Pylori Infection
Eligibility:
All Genders
30+ years
Phase:
PHASE4
Brief Summary
Based on a universal eradication of H. pylori in an offshore island (Matsu) with a high prevalence of gastric cancer as well as premalignant gastric lesion, we first examined the infection rate of H. ...
Detailed Description
Despite the decline of global incidence, gastric cancer still affects public health substantially due to the considerable medical burden in the treatment of disease at the symptomatic stage. This fact...
Eligibility Criteria
Inclusion
- Helicobacter pylori infection subjects
Exclusion
- Prior gastrectomy; pregnant women
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT00155389
Start Date
January 1 2004
End Date
December 1 2015
Last Update
November 14 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Lee Yi-Chia
Taipei, Taiwan, 10015
2
National Taiwan University Hospital
Taipei, Taiwan, 100